长氨酸 (PL-18) 的二基衍生物的NF-κB抑制活性
Yael Schlichter Kadosh1, Subramani Muthuraman2, Ariel Kushmaro1,3,4
1Avram and Stella Goldstein-Goren Department of Biotechnology Engineering, Ben Gurion University of the Negev, Beer Sheva 84105, Israel.
Journal of immunology research
|January 17, 2025
概括
皮珀龙胺衍生物PL-18有效地抑制了人类细胞中核因子卡帕B (NF-kB) 的激活. 这种化合物对开发慢性炎症和持久性感染的新疗法充满希望.
科学领域:
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
背景情况:
- 慢性炎症破坏组织平衡,由于其复杂的原因,缺乏有效的治疗方法.
- 核因子卡帕B (NF-kB) 是炎症反应的关键调节者.
研究的目的:
- 为了研究 piperlongumine (PL) -18 的抗炎潜力,它是一种 piperlongumine 的衍生物.
- 确定PL-18调节NF-kB信号的机制.
主要方法:
- 用PL-18对人类细胞系 (L428和A549) 的治疗.
- 评估NF-kB p65的核转位.
- 监测IκB激酶 (IKK) 的降解.
- 量化促炎性细胞因子的产生.
主要成果:
- 通过阻止L428和A549细胞中的p65核转位,PL-18抑制了NF-kB激活.
- PL-18诱导了IκB激酶 (IKK) 的降解.
- 在L428细胞中,PL-18减少了促炎性细胞因子的产生.
结论:
- 通过向NF-kB通路,PL-18显示出强大的抗炎活性.
- PL-18值得进一步研究,因为它是慢性炎症疾病的治疗候选者.
更多相关视频
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
11.3K
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
341
相关概念视频
NF-κB-dependent Signaling Pathway
7.2K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.2K
Transducer Mechanism: Nuclear Receptors
1.3K
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
1.3K
Opioid Receptors: Overview
481
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
481
